Astex has built a rich product portfolio with multiple drugs in preclinical and clinical development.
We also have a number of partnered products being developed under our collaboration and license agreements with major pharmaceutical companies including three approved drugs that are now on the market.
Latest from Astex
In the News
Astex wins the Research and Development Achievement Award at the Pharma Awards
FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer
OpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ
Sustaining Innovation
Sustaining Innovation Postdoctoral Training Program
Career Opportunities
We seek to attract and retain talented individuals who are passionate about improving patient outcomes.